ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CYTO Altamira Therapeutics Ltd

1.58
-0.06 (-3.66%)
04 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2014
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 0
Operating Income -5.86M
Pre Tax Income -5.86M
Net Income -5.86M
Preferred Dividends 0
Basic Earnings Per Share (EPS) 0
EBIT -5.86M
EBITDA -5.84M
Year End 31 December 2022 20152016201720182019202020212022
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 00000064k306k
Operating Income -30.88M-30.22M-25.39M-11.47M-7.26M-5.5M-17.1M-26.13M
Pre Tax Income -29.71M-30.79M-24.43M-11.33M-6.83M-8.22M-17.37M-26.54M
Net Income -29.71M-30.66M-24.41M-11.5M-6.63M-8.2M-17.39M-26.53M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.56-0.578-0.364-0.112-0.093-0.104-0.256-0.388
EBIT -30.88M-30.22M-25.39M-11.47M-7.26M-5.5M-17.1M-26.13M
EBITDA -30.79M-30.13M-25.27M-11.4M-7.23M-5.48M-15.49M-13.54M

Your Recent History

Delayed Upgrade Clock